首页> 外文OA文献 >FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model

【2h】

FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model

机译：FR255734，一种人源化的，Fc沉默的抗CD28抗体，可改善SCID小鼠牛皮癣异种移植模型中的牛皮癣

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Raychaudhuri Siba P.; Kundu-Raychaudhuri Smriti; Tamura Kouichi; Masunaga Taro; Kubo Kaori; Hanaoka Kaori; Jiang Wen-Yue; Herzenberg Leonore A.; Herzenberg Leonard A.;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. FR255734, a humanized, Fc-Silent, Anti-CD28 antibody, improves psoriasis in the SCID mouse-psoriasis xenograft model. [J] . Raychaudhuri SP, Kundu-Raychaudhuri S, Tamura K, The Journal of investigative dermatology. . 2008,第8期

机译：FR255734是一种人源化的Fc沉默抗CD28抗体，可改善SCID小鼠牛皮癣异种移植模型中的牛皮癣。
2. Kvl.3 in psorlatic disease: PAP-1, a small molecule inhibitor of Kvl.3 is effective in the SCID mouse psoriasis - Xenograft model [J] . Smriti Kundu-Raychaudhuri, Yi-Je Chen, Heike Wulff, Journal of Autoimmunity . 2014,第Null期

机译：Kvl.3在银屑病中：PAP-1，Kvl.3的一种小分子抑制剂，对SCID小鼠牛皮癣有效-异种移植模型
3. Kvl.3 in psorlatic disease: PAP-1, a small molecule inhibitor of Kvl.3 is effective in the SCID mouse psoriasis - Xenograft model [J] . Smriti Kundu-Raychaudhuri, Yi-Je Chen, Heike Wulff, Journal of Autoimmunity . 2014,第Null期

机译：KVL.3在牛肝性疾病中：PAP-1，kVL的小分子抑制剂在SCID小鼠牛皮癣 - 异种移植模型中是有效的
4. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model [C] . Thinzar M. Lwin, Kentaro Miyake, Takashi Murakami, Molecular-Guided Surgery: Molecules, Devices, and Applications IV . 2018

机译：荧光人源化抗CEA抗体在源自患者的原位异种移植（PDOX）小鼠模型中特异性标记转移性胰腺癌
5. Improving Antibody-Drug Conjugate Tumor Distribution and Efficacy Using Single-Cell Imaging and Multiscale Modeling [D] . Cilliers, Cornelius 2018

机译：使用单细胞成像和多尺度建模改善抗体药物结合的肿瘤分布和功效
6. Obinutuzumab (GA101) vs. rituximab significantly enhances cell death antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL [O] . Yaya Chu, Aradhana Awasthi, Sanghoon Lee, 2020

机译：ObInutuzumab（Ga101）与Rituximab显着增强了细胞死亡抗体依赖性细胞毒性并改善了异种移植Nod-Scid IL2RGNULL（NSG）小鼠模型中的CD20 +原发性纵隔B细胞淋巴瘤（PMBL）的整体存活率：潜在的靶向剂治疗PMBL.
7. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model [O] . Smriti Kundu-Raychaudhuri, Yi-Je Chen, Heike Wulff, 2014

机译：Kv1.3在银屑病中：PAP-1，kV1.3的小分子抑制剂在SCID小鼠牛皮癣 - 异种移植模型中是有效的

FR255734, a Humanized, Fc-Silent, Anti-CD28 Antibody, Improves Psoriasis in the SCID Mouse-Psoriasis Xenograft Model

著录项

引文网络

相似文献

相关主题

期刊订阅